All stock lists
AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
Healthcare · Medical Devices
15.20-0.31 (-2.00%)
Insider Score
––Not scored
RCEL Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
RCEL Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 21.70 M | 19.25 M | 17.61 M | 17.06 M | 18.42 M |
| Revenue Growth (YoY) | 17.83 % | — | — | — | — |
| Cost of Revenue | 3.94 M | 3.52 M | 3.30 M | 3.19 M | 3.47 M |
| Gross Profit | 17.77 M | 15.73 M | 14.31 M | 13.88 M | 14.95 M |
| SG&A Expense | 19.54 M | 18.90 M | 19.03 M | 19.28 M | 20.98 M |
| R&D Expense | 5.08 M | 5.63 M | 5.69 M | 3.75 M | 5.12 M |
| Operating Expenses | 24.62 M | 24.53 M | 24.72 M | 23.03 M | 26.10 M |
| Operating Income | -6.86 M | -8.80 M | -10.41 M | -9.15 M | -11.15 M |
| Pretax Income | -7.63 M | -10.62 M | -11.64 M | -13.17 M | -9.92 M |
| Tax Provision | 33.00 K | -11.00 K | -17.00 K | 15.00 K | 4.00 K |
| Net Income | -7.66 M | -10.61 M | -11.62 M | -13.19 M | -9.92 M |
| EPS (Basic) | -0.25 | -0.35 | -0.38 | -0.46 | -0.38 |
| EPS (Diluted) | -0.25 | -0.35 | -0.38 | -0.46 | -0.38 |
| Shares Outstanding | 30.75 M | 30.54 M | 30.38 M | 28.39 M | 26.37 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.